Takip et
Teofilo Vasconcelos
Teofilo Vasconcelos
BIAL
bial.com üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs
T Vasconcelos, B Sarmento, P Costa
Drug discovery today 12 (23-24), 1068-1075, 2007
20602007
Amorphous solid dispersions: Rational selection of a manufacturing process
T Vasconcelos, S Marques, J das Neves, B Sarmento
Advanced drug delivery reviews 100, 85-101, 2016
3892016
Gellan gum/pectin beads are safe and efficient for the targeted colonic delivery of resveratrol
FG Prezotti, FI Boni, NN Ferreira, DS Silva, SP Campana-Filho, A Almeida, ...
Polymers 10 (1), 50, 2018
492018
Measuring the emulsification dynamics and stability of self-emulsifying drug delivery systems
T Vasconcelos, S Marques, B Sarmento
European Journal of Pharmaceutics and Biopharmaceutics 123, 1-8, 2018
432018
Oral nanoparticles based on gellan gum/pectin for colon-targeted delivery of resveratrol
FG Prezotti, FI Boni, NN Ferreira, DS Silva, A Almeida, T Vasconcelos, ...
Drug Development and Industrial Pharmacy 46 (2), 236-245, 2020
422020
Multicomponent self nano emulsifying delivery systems of resveratrol with enhanced pharmacokinetics profile
T Vasconcelos, F Araujo, C Lopes, A Loureiro, J das Neves, S Marques, ...
European journal of pharmaceutical sciences 137, 105011, 2019
402019
Third-generation solid dispersion combining Soluplus and poloxamer 407 enhances the oral bioavailability of resveratrol
T Vasconcelos, F Prezotti, F Araújo, C Lopes, A Loureiro, S Marques, ...
International Journal of Pharmaceutics 595, 120245, 2021
392021
Development of a rapid dissolving ibuprofen solid dispersion
T Vasconcelos, P Costa
Pharm Res 16, 676-681, 2007
372007
The biopharmaceutical classification system of excipients
Vasconcelos, Teofilo, S Marques, bruno Sarmento
Therapeutic delivery 8 (2), 65-78, 2017
352017
Pharmaceutical composition for poorly soluble drugs
TC De Vasconcelos
US Patent App. 12/920,025, 2011
212011
Dosage form proportionality and food effect of the final tablet formulation of eslicarbazepine acetate: randomized, open-label, crossover, single-centre study in healthy volunteers
C Fontes-Ribeiro, T Macedo, T Nunes, C Neta, T Vasconcelos, ...
Drugs in R & D 9, 447-454, 2008
192008
Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa
US Patent 9,132,094, 2015
132015
Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
TC de Vasconcelos, RJDS Lima, PMDC Barrocas, LS de Castro Pereira, ...
132010
Polymer-based delivery systems for oral delivery of peptides and proteins
B Sarmento, D Ferreira, T Vasconcelos
Delivery Technologies for Biopharmaceuticals: Peptides, Proteins, Nucleic …, 2009
132009
Bioequivalence of final tablet formulation and research tablet formulation of eslicarbazepine acetate in healthy volunteers
R Lima, T Vasconcelos, R Cerdeira, M Lefebvre, E Sicard
J Bioequiv Availab 1 (3), 93-98, 2009
112009
Pharmaceutical composition comprising licarbazepine acetate
TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa
US Patent 8,372,431, 2013
9*2013
Composition
TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa
US Patent App. 12/257,240, 2009
82009
Solubility enhancement as strategies to improve oral bioavailability of poorly water soluble drugs
T Vasconcelos, B Sarmento, P Costa
Drug discovery today 12, 1281-1302, 2007
82007
Cell-based in vitro models for ocular permeability studies
T Vasconcelos, SB da Silva, D Ferreira, M Pintado, S Marques
Concepts and Models for Drug Permeability Studies, 129-154, 2016
62016
Cell-Based Intestinal In Vitro Models for Drug Absorption Screening
H Almeida, ACF Vieira, J Teixeira, MJ Gomes, P Barrocas, T Vasconcelos, ...
Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays, 1-22, 2022
52022
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20